Palisade Bio (PALI) EBITDA Margin Growth (1y) (2012 - 2020)
Powered by 
Analysis
Palisade Bio (PALI) EBITDA Margin Growth (1y) (2012 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -1,651.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -4.45 Mn |
| Sep 30, 2020 | 1.23 Mn |
| Jun 30, 2020 | -4.93 Mn |
| Mar 31, 2020 | 6.52 Mn |
| Dec 31, 2019 | -1.31 Mn |
| Sep 30, 2019 | -166,004.00 |
| Jun 30, 2019 | -2.35 Mn |
| Mar 31, 2019 | -430,280.00 |
| Dec 31, 2018 | -7.13 Mn |
| Sep 30, 2018 | 2.02 Mn |
| Jun 30, 2018 | 16.79 Mn |
| Mar 31, 2018 | 7.53 Mn |
| Dec 31, 2017 | 6.37 Mn |
| Sep 30, 2017 | 9.32 Mn |
| Jun 30, 2017 | -1.54 Mn |
| Mar 31, 2017 | 8.01 Mn |
| Dec 31, 2016 | 10.94 Mn |
| Sep 30, 2016 | 1.12 Mn |
| Jun 30, 2016 | 4.64 Mn |
| Mar 31, 2016 | -9.12 Mn |